Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report

BACKGROUND: Complement component 3 (C3) glomerulopathy, which includes dense deposit disease (DDD) and C3 glomerulonephritis, is caused by dysregulation of the alternative complement pathway. In most cases, C3 glomerulopathy manifests pathologically with membranoproliferative glomerulonephritis-like...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Nephrol
Hlavní autoři: Hirashio, Shuma, Satoh, Ayaka, Arima, Takahiro, Mandai, Kouichi, Awaya, Tadasuke, Oshima, Kumi, Hara, Shigeo, Masaki, Takao
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5934801/
https://ncbi.nlm.nih.gov/pubmed/29724182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-0905-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky